Molecular HPV PCR testing equipment - WHISE Grant

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 (VISN 22) is seeking to procure molecular HPV PCR testing equipment through a WHISE Grant solicitation. The procurement targets a high-throughput molecular analyzer capable of performing FDA-approved HPV analysis with specific technical requirements, including self-collect HPV molecular testing capabilities. Vendors must submit electronic quotes by April 7th, 2025, at 10:00 AM PDT, targeting businesses within NAICS Code 334516 with a size standard of 1,000 employees. The evaluation criteria will focus on the lowest-priced quotation that meets all technical requirements and demonstrates responsiveness to the solicitation's specifications. Contractors must provide an implementation plan within 90 days, maintain 90% monthly equipment uptime, and adhere to VA information security protocols.

The solicitation is not set aside for any specific business category and seeks to procure equipment for eight VA healthcare facilities across California, Arizona, and New Mexico. The contract anticipates purchasing eight units of specific equipment, including a Roche Cobas 5800 system, a Roche Infinity Laboratory Solutions One Time License, a printer, and an uninterruptible power supply. The place of performance is Phoenix, Arizona, with delivery specified as 90 days after receipt of order. While specific budget details are not explicitly stated, the procurement emphasizes acquiring new, authorized medical equipment with full manufacturer warranty and service conditions. The ultimate goal is to reduce workstation and labor requirements while maintaining CLIA and CLSI performance standards across participating VA healthcare system hospitals.